BD to Acquire Bard
Combination will create highly differentiated medical technology company focused on delivering innovative healthcare solutions to improve clinical and economic outcomes
Learn More
Select your country to refine your search, then choose from the BD and CareFusion product categories to the right.
Let the Rowa Vmax™ system provide your hospital with:
Learn More »
Let this automated dispensing system help:
Connect this system with HIT systems to:
Advance the standard of IV compounding. Let our solution help:
Avoid manual programming that creates risk of IV medication errors and safely deliver infusions, through:
Achieve Flow Cytometry Within Reach™, with a flow cytometer that offers:
Experience the fusion of safety, performance and sorting that:
The system may help manage the risk of IV injectable med errors and improve documentation accuracy through:
Modular, scalable and forward-compatible solutions integrated with our microbiology portfolio that:
Automate molecular diagnostic testing, with:
Designed to help you minimize the risk of IV catheter failure.
Key features:
Split-second protection from needlestick injuries
Use this one-step, broad-spectrum antiseptic to reduce infection-causing microorganisms on skin, as indicated by:
BD to Present at Investor Healthcare Conferences May 15, 2017
BD and UniteOR Join Forces to Deliver an Integrated Tracking Solution for the Operating Room Setting May 9, 2017
BD Announces Offerings of $2.25 Billion of Common Stock and $2.25 Billion of Depositary Shares Representing Interests in Mandatory Convertible Preferred Stock May 7, 2017